Dividend Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.39 USD | -1.04% | -16.45% | -9.63% |
Jan. 15 | Myriad Genetics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:45 PM | |
Jan. 15 | Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance | MT |
EPS & Dividend: Myriad Genetics, Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - | - | - |
EPS 2 | 0.06 | -3.08 | -0.35 | -1.39 | -3.18 | -1.112 | -0.6225 | -0.1067 |
Distribution rate | - | - | - | - | - | - | - | - |
Reference price 2 | 27.23 | 19.78 | 27.60 | 14.51 | 19.14 | 12.39 | 12.39 | 12.39 |
Nbr of stocks (in thousands) | 74,389 | 75,210 | 79,855 | 81,034 | 88,669 | 91,035 | 91,035 | - |
Announcement Date | 8/13/19 | 2/23/21 | 2/24/22 | 2/28/23 | 2/27/24 | - | - | - |
Upcoming events: Myriad Genetics, Inc.
2025-03-03 | Q4 2024 Earnings Release (Projected) |
2025-04-30 | Q1 2025 Earnings Release (Projected) |
2025-07-30 | Q2 2025 Earnings Release (Projected) |
2025-11-03 | Q3 2025 Earnings Release (Projected) |
Yield | Yield | P/E ratio | Price to Book | EV / Sales | ||
---|---|---|---|---|---|---|
-.--% | -.--% | -11.14x | 1.555 | 1.26x | ||
+0.83% | +0.94% | 27.9x | 3.180 | 3.28x | ||
+1.97% | +2.40% | 24.3x | 5.382 | 9.85x | ||
- | - | 15.7x | - | 3.96x | ||
+1.06% | +1.19% | 30.52x | 3.264 | 5.09x | ||
-.--% | -.--% | -10.81x | -42.416300 | 6.75x | ||
+2.96% | +3.49% | 17.27x | 2.482 | - | ||
+0.55% | +0.68% | 53.06x | 2.159 | 8.04x | ||
- | - | - | - | - | ||
-.--% | -.--% | -10.59x | 2.509 | 2.36x | ||
Average | +0.92% | +1.09% | 15.14x | -2.74 | 5.08x | |
Weighted average by Cap. | +1.05% | +1.23% | 20.23x | -1.97 | 5.22x |